Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
<strong>Objectives<br></strong> Many regions of Africa have experienced lower COVID-19 morbidity and mortality than Europe. Pre-existing humoral responses to endemic human coronaviruses (HCoV) may cross-protect against SARS-CoV-2. We investigated the neutralizing capacity of SARS-C...
Main Authors: | Nyagwange, J, Kutima, B, Mwai, K, Karanja, HK, Gitonga, JN, Mugo, D, Sein, Y, Wright, D, Omuoyo, DO, Nyiro, JU, Tuju, J, Nokes, DJ, Agweyu, A, Bejon, P, Ochola-Oyier, LI, Scott, JAG, Lambe, T, Nduati, E, Agoti, C, Warimwe, GM |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2022
|
Registos relacionados
-
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
Por: James Nyagwange, et al.
Publicado em: (2023-02-01) -
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
Por: Nyagwange, J, et al.
Publicado em: (2021) -
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.
Por: Rachel Ochola, et al.
Publicado em: (2009-12-01) -
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
Por: Uyoga, S, et al.
Publicado em: (2021) -
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21
Por: Lucinde, RK, et al.
Publicado em: (2022)